Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.6.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.6.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.6.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GY.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GY.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GY.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XCWORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XCWENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCWENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCWNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.2.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.2.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.2.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.2.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.2.3.21ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.2.3.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.21NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FL.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.108ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.108ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.108ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.108NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JS.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JS.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
JS.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.104ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.104ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.104ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.104NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HH.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HH.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FL.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FL.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used